tiprankstipranks
Sanofi (DE:SNW)
XETRA:SNW
Germany Market
SNW
Sanofi
RESEARCH TOOLSreports

Sanofi (SNW) Stock News & Sentiment

Compare
31 Followers
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Premium
Company Announcements
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
10d ago
SNYNF
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
Premium
Company Announcements
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
12d ago
SNYNF
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
Premium
Company Announcements
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
25d ago
REGN
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
Premium
Company Announcements
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
2M ago
REGN
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
Premium
Ratings
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
2M ago
SNY
Is SNYNF a Buy, Before Earnings?
Premium
Pre-Earnings
Is SNYNF a Buy, Before Earnings?
2M ago
Sanofi Completes Key Amlitelimab Vaccine-Response Study in Atopic Dermatitis
Premium
Company Announcements
Sanofi Completes Key Amlitelimab Vaccine-Response Study in Atopic Dermatitis
2M ago
SNYNF
More DE:SNW News >

SNW News on the Web

Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis
rttnews
Bullish
Weekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses
rttnews
Bullish
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
CNBC
Bearish
Sanofi: CHMP Adopts Positive Opinion Recommending Approval Of Sarclisa
rttnews
Bullish
Sanofi (ENXTPA:SAN) Valuation Check After Dupixent Secures Japanese Approval In Rare Skin Disease
Simply Wall St
Neutral
Jefferies Keeps Their Buy Rating on Sanofi (SNYNF)
TipRanks News
Bullish
Deutsche Bank Remains a Buy on Sanofi (SNYNF)
TipRanks News
Bullish
Sanofi (SNYNF) Gets a Hold from J.P. Morgan
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
DE:SNW
Sector Average
Media Buzz
This Week14 articles
Weekly Average9.5 articles
News Sentiment
This Week90%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SNW’s Media Buzz Sentiment?
14 articles about DE:SNW were published this week. In an average week, 9.5 articles are published.
    What is DE:SNW’s weekly average amount of articles?
    In an average week, 9.5 articles about DE:SNW are published.
      What is DE:SNW’s News Sentiment?
      90% of articles about DE:SNW were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        PYXSPyxis Oncology
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
        Showing the stocks with the most bullish news sentiment over the past week